A 37-year-old woman’s experience with a delayed rectal cancer diagnosis underscores a worrying increase in the disease among younger adults, with death rates rising faster than those for colon cancer. Medical professionals are urging increased awareness of symptoms and proactive medical attention.

Ashleigh Wolsey’s Story

Ashleigh Wolsey, a 37-year-old logistics worker, initially attributed changes in her bowel habits to a recurrence of irritable bowel syndrome (IBS) she had as a teenager. She experienced alternating periods of constipation and frequent, incomplete bowel movements, often accompanied by pain.

The appearance of blood in the toilet bowl during a flight to Madrid prompted her to seek medical help. Initial blood tests and a FIT test (checking for trace blood in stool) were inconclusive, and doctors initially attributed her symptoms to IBS.

Diagnosis and Stage

However, Ashleigh persisted, citing her father’s death from stomach cancer at age 55, which led to a referral for a colonoscopy. The colonoscopy revealed a 1.5-inch tumor in her rectum, later diagnosed as stage three rectal cancer, indicating it had spread to nearby lymph nodes.

A Growing Trend

Ashleigh’s diagnosis coincides with a concerning trend of rising rectal cancer cases in younger adults. While bowel cancer rates are declining in older populations due to increased screening, diagnoses in individuals under 45 are steadily increasing.

Recent research from the US indicates that deaths from rectal cancer in this age group are rising up to three times faster than deaths from colon cancer. Researchers predict this trend will continue for at least another decade, with rectal cancer identified as a major driver of the early-onset bowel cancer epidemic.

Understanding Rectal Cancer

Experts emphasize that colorectal cancer is no longer solely a disease of older adults, and early action is crucial. Rectal cancer affects approximately 16,000 people in Britain annually, developing in the final section of the large bowel.

Symptoms and Detection

Many symptoms of rectal cancer overlap with those of other conditions like IBS, leading to delays in diagnosis. Up to three in four younger patients are diagnosed only after the cancer has already spread, complicating treatment.

Early detection, when the cancer is confined to the bowel, yields a five-year survival rate of around 91%. This rate drops to 74% with nearby spread and a mere 13% with distant metastasis. Common symptoms include blood in stool, abdominal pain, changes in bowel habits, iron deficiency, unexplained weight loss, and bloating.

The case highlights the importance of advocating for oneself and seeking further investigation when initial assessments are inconclusive, especially with a family history of cancer. Greater awareness and proactive screening strategies are needed to address the increasing incidence of rectal cancer in younger individuals.